- Investing Ideas
- /
- U.S. Strong Balance Sheet Stocks
U.S. Strong Balance Sheet Stocks
Results
3734
0 new
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3,734 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PBIP | US$15.13 | -0.7% | 9.6% | US$117.7m | US$15.00 | PB1x | E87.9% | 1.9% | Banks | ||
TREC | US$9.81 | 0.3% | 16.6% | US$232.6m | n/a | PE25.9x | n/a | n/a | Materials | ||
FFHL | US$8.30 | 0.7% | 8.1% | US$27.1m | n/a | PE2.8x | n/a | n/a | Materials | ||
RADA | US$9.87 | -2.4% | 5.0% | US$490.9m | US$14.00 | PE85x | E83.7% | n/a | Capital Goods | ||
YMTX | US$13.23 | -8.3% | -41.3% | US$143.6m | n/a | PS29.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
SREV | US$1.50 | 0.7% | 2.0% | US$150.2m | n/a | PS0.8x | n/a | n/a | Software | ||
SCX | US$16.18 | 0.1% | 52.4% | US$118.7m | n/a | PE9.7x | n/a | 0% | Capital Goods | ||
LBAI | US$13.43 | 0.9% | 0.5% | US$875.0m | US$16.05 | PB0.7x | E4.3% | 4.3% | Banks | ||
ALPN | US$64.97 | 0.03% | 518.2% | US$4.5b | US$62.00 | PS78.9x | E-9.9% | n/a | Pharmaceuticals & Biotech | ||
TALS | US$27.20 | -4.9% | 91.5% | US$553.2m | US$200.00 | PB3.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
SCPL | US$22.94 | 0.04% | 68.7% | US$2.9b | US$22.96 | PE20.9x | E8.7% | n/a | Media | ||
EQRX | US$2.34 | -5.3% | -36.2% | US$1.1b | n/a | PB1x | S123.3% | n/a | Pharmaceuticals & Biotech | ||
NGM | US$1.54 | -3.1% | -59.8% | US$128.5m | US$1.55 | PS29.1x | E14.7% | n/a | Pharmaceuticals & Biotech | ||
CWBC | US$15.48 | 2.2% | 22.3% | US$137.0m | US$18.00 | PB1.2x | n/a | 2.1% | Banks | ||
KDNY | US$40.39 | 0.3% | 95.7% | US$2.9b | US$40.09 | PS495.8x | E22.6% | n/a | Pharmaceuticals & Biotech | ||
TCFC | US$27.09 | -2.7% | -25.3% | US$153.6m | US$37.00 | PB0.8x | n/a | 2.6% | Banks | ||
ELVG | US$0.02 | 0% | n/a | US$8.3m | n/a | PE41.3x | n/a | n/a | Commercial Services | ||
CSHX | US$59.00 | 0% | 31.1% | US$214.3m | n/a | PB0.9x | n/a | 2.9% | Banks | ||
CFB | US$17.95 | 5.0% | 57.2% | US$885.4m | US$20.00 | PB1.1x | E9.6% | n/a | Banks | ||
DNTH | US$23.45 | -0.6% | 108.1% | US$661.2m | US$51.80 | PS129.3x | E-17.8% | n/a | Pharmaceuticals & Biotech | ||
FINV | US$6.24 | 3.5% | 40.2% | US$1.6b | US$7.38 | PE5.3x | E11.8% | 3.3% | Diversified Financials | ||
NEPH | US$1.54 | -3.1% | -30.9% | US$15.9m | US$4.75 | PS1.2x | E128.2% | n/a | Capital Goods | ||
VNDA | US$5.05 | 1.4% | 41.9% | US$296.8m | US$10.43 | PS1.5x | E86.9% | n/a | Pharmaceuticals & Biotech | ||
PJT | US$166.85 | 6.7% | 89.9% | US$3.9b | US$140.00 | PE36.6x | S9.7% | 0.6% | Diversified Financials |